Clene Granted In-Person Meeting With FDA Senior Leadership to Discuss CNM-Au8 Biomarker and Related Clinical and Survival Data
For CNM-Au8, Clene has more than 700 patient-years of safety data that show no significant safety concerns or safety trends identified. No serious adverse events (SAEs) have been identified as related ...
US FDA declines to approve Vanda's stomach condition drug
The U.S. Food and Drug Administration has declined to approve Vanda Pharmaceuticals' drug to treat stomach paralysis symptoms ...
Analysis
Your food may soon come with warning labels
TGIF! We’re happy to be in the Health Brief driver’s seat today. What do you think of the potential new labels your favorite foods might get? Tell us all at [email protected] and ...
Investopedia12d
Food and Drug Administration (FDA): What It Is and Does
Her expertise is in personal finance and investing, and real estate. The Food and Drug Administration (FDA) is a government agency that is responsible for the promotion and protection of public ...
The FDA wants to place warning labels on food packages to combat obesity and other health conditions
The Food and Drug Administration (FDA) is looking to propose the inclusion of front-of-package warning labels that detail the ...
Weight loss drug liraglutide shows promise for younger children with obesity, study finds
Children who used the weight loss drug liraglutide in a late-stage trial lost significantly more weight than children who got ...
verywellhealth2d
Types of Medications for Heart Attack Prevention and Treatment
If you’ve experienced a heart attack, your healthcare provider may prescribe certain medications to help prevent one from ...
US FDA approves Eli Lilly's drug for eczema
Eli Lilly said on Friday the U.S. Food and Drug Administration approved its eczema drug for use in adults and children above ...
Lead, arsenic and other heavy metals in tampons prompt FDA investigation
The FDA said that it will examine the potential harm to women of heavy metals such as lead and arsenic found in tampons.
BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) Announces Upcoming In-Person FDA Meeting to Discuss CNM-Au8
Clene (NASDAQ: CLNN), a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, will be meeting in ...
Times-News1d
HEALTH CARE BUZZ: Alzheimer’s: Diagnosed, Treatment and Stages, Part 2
By 2060, 14 million people will be living with Alzheimer’s, the fifth-leading cause of death in people 65 and older.
CNN11d
Weight loss drug liraglutide shows promise for younger children with obesity, study finds
Children who used the weight loss drug liraglutide ... use to determine whether a person has obesity. Liraglutide was approved by the US Food and Drug Administration in 2014 to help adults lose ...